Kiora Pharmaceuticals (KPRX) Acquisitions (2016)
Kiora Pharmaceuticals' (KPRX) quarterly Acquisitions came in at $185746.0 in Q1 2016.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Acquisitions (2016) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has reported Acquisitions for 1 consecutive years, with $185746.0 the latest figure, recorded in Q1 2016.
- For the quarter ending Q1 2016, Acquisitions changed N/A year-over-year to $185746.0; the trailing twelve-month figure through Dec 2016 stood at $185746.0 (changed N/A YoY), and the FY2021 full-year result was $93155.0, down 15.81% from the prior year.
- Acquisitions held at $185746.0 in Q1 2016 per KPRX's latest filing.
- Across five years, Acquisitions topped out at $185746.0 in Q1 2016 and bottomed at $185746.0 in Q1 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -17.24 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | - |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -23.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | - |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Kiora Pharmaceuticals | 15.75 Mn | 15.75 Mn | - | - |